The Butterfly Network returning to my life has to mean something. Baird downgrades Xponential Fitness to Neutral after rally » 06:59 XPOF Van shall we boot today and free up $'s-?
I went down behind the house and the gas tank does have a shut off valve so before i move the dryer and washer unit out of it's enclave and possibly pop that line-- I'll turn off the gas downstairs! Fluence Energy upgraded to Buy from Neutral at Guggenheim 06:42 FLNC
Baron is off to Dutch Brothers Today! After his review of a double cold something... WE BUY!-> Dutch Bros upgraded to Outperform from Neutral at Wedbush 06:28 BROS
This Parsons has more good news in the past 2 weeks than any other company that I can think of. Parsons rolls out first delivery of 13 total RABDO to U.S. Air Force 06:27 PSN
Welcome to the Network Cathie. Cathie Wood's ARK Investment bought 2.61M shares of Butterfly Network today 20:08 BFLY
Ryanair traffic rose 12% Y/Y in March Apr. 04, 2023 2:03 PM Low-cost carrier Ryanair (NASDAQ:RYAAY) flew 12.6M passengers in March vs. 10.6M in February 2023 and 11.2M passengers in March 2022. Load factor was 93% for the month vs. 87% year ago. The carrier operated over 71,350 flight during the month. The airline flew 168.6M passengers over the past 12 months.
Ocean Wind I project may 'adversely affect' but not kill whales, NOAA says Lets let the whales have a say in this...
Here is a stock I haven't heard about in ages. Back in the day these guys were one of about five military contractor plays-- then they vanished or half way merged.. DRS Leonardo DRS, Inc. $13.340.47(+3.65%)4:00 PM 04/04/23 NASDAQ |$USD |Pre-Market:$14.19+0.85(+6.37%)<----------- Leonardo DRS (NASDAQ:DRS) said Tuesday it got contract worth over $1 billion to provide the U.S. Navy integrated electric propulsion components for its next-generation Columbia-class submarine. "The Columbia-class submarine is a top priority program for the U.S. Navy and will replace the fleet of Ohio-class ballistic missile submarines," the company said. The integrated electric propulsion components will be made at company’s Fitchburg, Massachusetts, Menominee Falls, Wisconsin, and Danbury, Connecticut facilities. Additional content will be manufactured in the DRS High Ridge, Missouri facility.
Solo Brands price target raised to $11 from $9 at Piper Sandler 08:12 DTC Fire Pit madness! This has been one of my best calls- I believe I brought it hear at $3// it was supposed to be the X-mas gift of the year last year and it turns out it was. Now I want to be totally upfront- my automatic tennis bag that shoots the friendless tennis player balls to hit,that did not turn out to be the X-mas gift of the year before... And my idea for next Christmas the electric golf cart is still decidedly up in the air. But I nailed the fire pit!
TIME MACHINE GAME- Playting the time machine game is a great way to buy stocks. It's abit perverted but you have an idea and you watch it-- INZY. lets go back to Feb-- Inozyme Pharma Inc (NASDAQ:INZY) announced topline pharmacokinetic (PK), pharmacodynamic (PD), and safety data from the ongoing Phase 1/2 trials of INZ-701 in ENPP1 Deficiency and ABCC6 Deficiency (PXE). Rapid, significant, and sustained increase in plasma pyrophosphate (PPi) was observed, and an encouraging patient-reported outcome data in all dose cohorts in the ENPP1 Deficiency trial. Also Read:Gummybear advisors secures top ranking usa PPi plays a significant role in inhibiting dystrophic calcification. Rapid and significant increase in PPi was observed in all dose cohorts, with a sustained increase observed in the highest dose cohort in the PXE trial. INZ-701 was generally well-tolerated and exhibited a favorable safety profile in both trials. Inozyme Pharma expects to report cash, cash equivalents, and short-term investments of approximately $127.9 million as of December 31, 2022. The company anticipates that its cash balance, together with the additional $20 million borrowed on February 15, 2023, under its existing debt facility, will enable it to fund cash flow requirements into the fourth quarter of 2024, representing an increase of two quarters over its previous guidance. Price Action: INZY shares are up 26.6% at $2.81 during the premarket session on the last check Thursday Ok a nice 26% move nothing crazy.,....... TODAY- $5.00. The stock has basically doubled since Feb and nobody has said a word. The quiet passage in the Time Machine... I showed insider buying here--- so we know that management and the investor are on the same side.But the exciting thing is the IB didn't happen befre the move at $2... it just happened: Inozyme director Hopfner buys $1.6M in company shares 17:53 INZY Inozyme Pharma Director Robert Hopfner disclosed in a regulatory filing, that he had purchased 344,592 shares of company stock at $4.54 per share on March 29, for a total transaction amount of $1,563,724. idea of the day- Inozyme Pharma (INZY)-$5.15 <-----------